Showing results (21-30 of 180) with videos related to

Sort By:
Pageof 18
Oncotarget|November 8, 2017
Azacitidine or intensive chemotherapy for older patients with secondary or therapy-related acute myeloid leukemiaPierre-Yves Dumas, Sarah Bertoli, Emilie Bérard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2020
FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationEduardo Rodríguez-Arbolí, Myriam Labopin, Johanna Tischer, et al.
Bone Marrow Transplantation|June 30, 2022
Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)Arnon Nagler, Myriam Labopin, Jan J Cornelissen, et al.
Haematologica|August 16, 2019
Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulinFrédéric Baron, Jacques-Emmanue Galimard, Myriam Labopin, et al.
Haematologica|May 4, 2019
Allogeneic stem cell transplantation using HLA-matched donors for acute myeloid leukemia with deletion 5q or monosomy 5: a study from the Acute Leukemia Working Party of the EBMTXavier Poiré, Myriam Labopin, Emmanuelle Polge, et al.
Leukemia|March 9, 2019
Prognostic significance of recurring chromosomal abnormalities in transplanted patients with acute myeloid leukemiaJonathan Canaani, Myriam Labopin, Maija Itälä-Remes, et al.
Oncotarget|February 10, 2018
Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remissionFrancesco Saraceni, Myriam Labopin, Rose-Marie Hamladji, et al.
Blood|March 6, 2016
Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseEdouard Forcade, Haesook T Kim, Corey Cutler, et al.
Bone Marrow Transplantation|July 11, 2021
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMTFrédéric Baron, Maud Ngoya, Myriam Labopin, et al.
Blood Cancer Journal|April 14, 2019
Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMTFrédéric Baron, Myriam Labopin, Annalisa Ruggeri, et al.
Pageof 18